SunLink Health Systems
SSY
Market cap $5.98M

0.8500 USD

+0.0000

0.00%

Updated Oct 22, 9:33 AM EDT

1 day

0.00%

5 days

4.81%

1 month

-2.30%

3 months

0.00%

6 months

16.44%

Year to date

-9.57%

1 year

19.72%

5 years

-26.72%

Healthcare General Medical & Surgical Hospitals

0

Funds holding %

of 6,740 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 12 [Q1] → 13 (+1) [Q2]

7% more capital invested

Capital invested by funds: $708K [Q1] → $757K (+$49.4K) [Q2]

0.32% less ownership

Funds ownership: 13.79% [Q1] → 13.47% (-0.32%) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SSY.

See Analyst Rankings

Financial journalist opinion

SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., and an affiliate, have completed the sale of the hospital building and related real estate of its formerly operated Trace Regional Hospital in Houston, Mississippi for approximately $2,000,000. The company said the net proceeds of approximately $1,932,000 will be retained for working capital and general corporate purposes. The company exp.

SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate

SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth fiscal quarter ended June 30, 2024 compared to a loss from continuing operations of $1,021,000 (or a loss of $0.15 per fully diluted share) for the fourth fiscal quarter ended June 30, 2023. Earnings from discontinued operations were $4,940,000 (or earnings of $0.70 per fully diluted share) for the f.

SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results

SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE:AMERICAN: SSY) today announced that its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi for approximately $7,100,000. The company said the net proceeds of approximately $6,500,000 will be retained for working capital and general corporate purposes. The company expects to recognize a pre-tax gain.

SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab

SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a loss of $0.06 per fully diluted share) for the third fiscal quarter ended March 31, 2023. Net loss for the quarter ended March 31, 2024 was $1,396,000 (or a loss of $0.20 per fully diluted share) compar.

SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results

SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended December 31, 2022. Net loss for the quarter ended December 31, 2023 was $3,075,000 (or a loss of $0.44 per fully diluted share) c.

SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its indirect subsidiary, Southern Health Corporation of Houston, Inc. (“Southern”), has reached a revised agreement for the sale of Trace Regional Hospital and three (3) patient clinics in Chickasaw County, MS, (“Trace”) to Progressive Health of Houston, LLC (“Progressive”). Southern sold certain personal and intangible property to Progressive for $500,000 pursuant to an asset purchase agreement, e.

Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics

SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) today announced that SunLink and Progressive Health Group, LLC (“Progressive”) have amended their previously-announced agreement for the sale by SunLink's subsidiary, Crown Healthcare Investments, LLC, of Trace Regional Medical Center in Houston, Mississippi, to Progressive to, among other things, extend the closing date until January 31, 2024, on substantially the same price and terms previously announced.

SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center

SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results

ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2023 compared to a loss from continuing operations of $605,000 (or a loss of $0.09 per fully diluted share) for the first fiscal quarter ended September 30, 2022. On November 10, 2023, the Company's subsidiary, Crown Healthcare Investments, LLC, signed an agreement w.

SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results

See News Rankings

Charts implemented using Lightweight Charts™